Sign In   |   Register
News: General

Announcing the recipient of the Anitschkow Prize 2016

25 February 2016  

The Anitschkow Prize in Atherosclerosis Research

EAS is pleased to announce that Professor Peter Carmeliet, Belgium will be the recipient of this year’s Anitschkow Prize. This prestigious Prize, awarded annually by EAS, recognizes outstanding research in the field of atherosclerosis and linked metabolic disturbances.

Professor Carmeliet receives the Prize in recognition of the originality and novelty of his work and the promise for future high impact work to follow. The impact of his work is evident in many medical fields, not the least within cardiovascular disease.

Professor Carmeliet is an internationally recognised leader in field of angiogenesis and endothelial cell metabolism and publishes regularly in first rank journals on the central theme of his work. The disease focus is cancer, vascular disease and dementia, with publications covering both basic/molecular science and clinical/ translational aspects. He focuses on unravelling the molecular basis of angiogenesis and translating these genetic insights in therapeutic concepts and, if possible, novel treatments.

Peter Carmeliet is a physician and professor at the Katholieke Universiteit Leuven (Leuven, Belgium). He is former director (2008-2015) of the Vesalius Research Center, VIB - KU Leuven and is heading the Laboratory of Angiogenesis and Vascular Metabolism at the VRC. Professor Carmeliet is the recipient of numerous awards, including InBev-Baillet Latour health prize (2010), Ernst Jung-Priz für Medizin (2010), the Blaise Pascal Medal in Medicine and Life Sciences by the European Academy of Sciences (2011), the Münster Heart Center Award (2015), and award of the Noble title of Baron, granted by King Filip of Belgium (2015).


EAS is pleased to announce that Professor Peter Carmeliet, Leuven, Belgium, will be the recipient of the prestigious Anitschkow Prize 2016. Professor Carmeliet will present this year’s Anitschkow Lecture “Endothelial cell metabolism: a novel player in atherosclerosis? Basic principles and therapeutic opportunities” as part of the Opening Ceremony at EAS Congress Innsbruck, May 29, 2016.

More about the Congress Programme >>

The Anitschkow Prize

This prestigious Prize, awarded annually by EAS, recognizes outstanding research in the field of atherosclerosis and linked metabolic disturbances.

Previous Anitschkow Prize recipients are: Prof. Aldons “Jake” Lusis, USA (2015), Prof. John Kastelein, The Netherlands, (2014), Prof. Peter Libby, USA (2013), Prof. Terje R Pedersen, Norway (2012), Prof. Philip Barter, Australia (2011), Prof. Michael Brown, USA (2010), Prof. Jean-Claude Fruchart, France (2008), and Prof. Göran Hansson, Sweden (2007).

Read more about the Anitschkow Prize >>

Professor Carmeliet at EAS 2016

Professor Carmeliet is also one of the plenary speakers at EAS 2016. Do not miss his lecture Angiogenesis and endothelial cell dysfunction in atherosclerosis: a novel target for treatment” during the plenary sessions on Tuesday May 31, between 8:30 and 10:30.

To the congress programme >>
Register to the congress, early registration before 9 March >>



Membership Software Powered by YourMembership.com®  ::  Legal